Compare Lowe`s Companies Inc (LOW) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lowe`s Companies Inc vs Summit Therapeutics Inc — how do they compare? Lowe`s Companies Inc trades at $218 (market cap $121.10B), while Summit Therapeutics Inc trades at $14.02 (market cap $12.06B). The key difference: Lowe`s Companies Inc is far larger — about 10× Summit Therapeutics Inc's market cap, and Lowe`s Companies Inc pays a 2.32% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| LOW | SMMT | |
|---|---|---|
Market Cap | $121.10B | $12.06B |
Sector | Consumer Cyclical | Health |
52-Week High | $287.39 | $26.98 |
52-Week Low | $201.92 | $12.55 |
Enterprise Value | $162.85B | $11.39B |
Dividend Yield | 2.32% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lowe`s Companies Inc
Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
